Document is current
Any future updates will be listed below
-
Authors
Becker, Russell E. N.
Daignault-Newton, Stephanie
Shoemaker, Elaina
Sitek, Dennis
Thelus, Jennifer M. https://orcid.org/0009-0002-5952-9833
Clark, Sabrina
Martin-Schwarze, Adam
Spino, Catherine
Carlozzi, Noelle E.
Meurer, William J.
Sales, Anne E.
Dauw, Casey A.
Ghani, Khurshid R.
-
Funding
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (CER-2021C2-22856)
- License Information
-
More Information
Article History
Received: 13 August 2024
Accepted: 28 October 2024
First Online: 4 December 2024
Declarations
:
: The SOUL study has received IRB approval by WCG (24 May 2023, protocol #20232054), which will serve as the central IRB for all participating performance sites. Written, informed consent to participate will be obtained from all participants.
: This manuscript does not contain individual personal data from patients.
: KRG is a consultant to medical device companies in the field of stone disease: Olympus, Boston Scientific, Ambu, Coloplast. KRG has investigator funding for a clinical trial funded by Coloplast. CAD is a consultant to medical device companies in the field of stone disease: Boston Scientific, Cook Medical. The remaining authors declare that they have no competing interests.
